AUAUniversity26 Sep 2025

The Latest Breakthroughs in LG-IR-NMIBC (2025)

The Latest Breakthroughs in LG-IR-NMIBC (2025) CME Available: auau.auanet.org/node/43689 After participating in this CME activity, participants will be able to: 1. Apply updated clinical evidence and treatment protocols for low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC) in appropriate patient cases to reduce recurrence rates and improve clinical outcomes. 2. Improve clinical decision-making related to risk stratification and surveillance strategies for low-grade, intermediate-risk NMIBC based on pathophysiology, epidemiology, and progression patterns. 3. Support evidence-based, patient-centered treatment selection options for low-grade, intermediate-risk NMIBC by comparing traditional intravesical therapies with emerging treatments. 4. Interpret the efficacy and safety profiles of new therapies to appropriately integrate new therapeutic options into clinical practice (upon regulatory approval). 5. Utilize new medications in the evolving treatment landscape following an evaluation of key clinical trial data from recent studies. 6. Assess the impact of treatment options on patient-reported outcomes, including quality of life and treatment burden, to guide shared decision-making and optimize care delivery. ACKNOWLEDGEMENTS Support provided by an independent educational grant from: UroGen Pharma, Inc.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Core Curriculum: Pediatric Oncology

Core Curriculum: Pediatric Oncology Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Amanda F. Buchanan, MD AUA Urology Core Curriculum: https://cme.auanet.org/Page/Core-Curriculum Outline: Segment 1: R...

30 Sep 30min

Starting HoLEP without Fellowship Training

Starting HoLEP without Fellowship Training Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Daniel S. Kellner, MD

23 Sep 26min

AUA Guidelines: Vasectomy

AUA Guidelines: Vasectomy Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Richard Lee, MD, MBA To access the full guideline, please use the following link: https://www.auanet.org/guidelines-and-quality/...

16 Sep 24min

Microultrasound for the Detection of Prostate Cancer

Microultrasound for the Detection of Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Christian P. Pavlovich, MD

9 Sep 24min

AUA Guidelines: Non-Muscle Invasive Bladder Cancer

AUA Guidelines: Non-Muscle Invasive Bladder Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guests: Peter E. Clark, MD and Jeffrey M. Holzbeierlein, MD, FACS To access the full guideline, please use th...

3 Sep 33min

Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease

Update Series (2026): Evaluating Abnormal Urine Cytology Without Clinically Demonstrable Urinary Tract Disease Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Sherri M. Donat, MD Now in its 45th install...

2 Sep 21min

AUA2026: Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update

AUA2026: Advanced Prostate Cancer in the News 2026: A Case-Based Multidisciplinary Update CME Available: https://cme.auanet.org/URL/26DC010ONL LEARNING OBJECTIVES: At the conclusion of this activity...

24 Aug 1h 31min

AUA2026: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology

AUA2026: Should I Order a PET Scan? Integrating Molecular Imaging into Urologic Oncology Clinical Practice: Current Approaches and Future Opportunities CME Available: https://cme.auanet.org/URL/26DC0...

21 Aug 1h 47min